肝性脑病

ɡān xìnɡ nǎo bìnɡ
  • hepatic encephalopathy;hepatic coma;hepatic encephalapathy;hepatoencephalopathy
肝性脑病肝性脑病
  1. 进一步的多元回归分析提示:PTA、尿素氮、血钠、肝性脑病为影响预后的独立的危险因素。

    ( P < 0.01 ) Among them , some factors including PTA , Urea , sodium in blood and hepatic coma are independent risk factors of prognosis .

  2. 结果:3例治疗前伴肝性脑病患者昏迷程度减轻。

    Results : 3 patients with hepatic coma improved in level of encephalopathy .

  3. MR脑血流灌注成像在亚临床肝性脑病中的应用

    Application of contrast-enhanced perfusion MR imaging in patients with subclinical hepatic encephalopathy

  4. I期或II期肝性脑病中口-盲肠通过时间的延长

    Increased oro-cecal transit time in grade I or II hepatic encephalopathy

  5. 我们甚至可以给II级肝性脑病患者提供蛋白质。

    You can feed people even with grade II encephalopathy with protein .

  6. 肝性脑病患者脑MRI的信号特点

    Signal characteristic of cerebral MRI in hepatic encephalopathy

  7. 目的:分析总结肝性脑病患者脑MRI的信号特点。

    Objective : To analyze and summarize the cerebral MRI signal characteristics of hepatic encephalopathy .

  8. PURE技术校正MRI信号强度评价亚临床肝性脑病的临床应用价值

    The Evaluation of Image Signal Intensity Correction Using PURE Technique in Patients with Subclinical Hepatic Encephalopathy

  9. 16排螺旋CT门静脉造影对肝硬化病变程度的评价及其与肝性脑病风险相关性的研究

    Multi-detector Row Spiral CT in Evaluating the Degree of Liver Cirrhosis and the Correlation with Episode Risks of Encephalopathy

  10. 补Zn可以缓解酒精性肝损害的某些临床表现和肝性脑病的病情。

    Zinc supplementation can improve some manifestation of ethanol liver injury and hepatic encephalopathy .

  11. 亚临床期肝性脑病MRI及脑血流灌注成像的研究

    The Study of MRI Appearances and Contrast Enhanced Perfusion MR Imaging in Patients with Subclinical Hepatic Encephalopathy

  12. 急性重症肝炎患者发生肝性脑病危险因素多元Logistic回归研究

    Multivariate Logistic Regression Analysis on Risk Factors of Hepatic Encephalopathy in Patients with Acute Sever Hepatitis

  13. PET测定肝硬化急性肝性脑病期间的~(13)N-氨在脑组织中的代谢状况

    Brain metabolism of ~ ( 13 ) N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography

  14. 肝性脑病患者中神经介质内皮素,血栓素B2和6-酮-前列腺素F1α的变化

    Changes of neurotransmitter endothelin , thromboxance B_2 and 6-keto-prostaglandin F1 alpha in patients with hepatic encephalopathy and clinical significance

  15. 实验性肝性脑病小鼠GABA受体分析

    The changes of GABA receptors in mice with experimental hepatic encephalopathy

  16. 经TIPS途径治疗急性、亚急性门静脉血栓临床疗效经颈静脉肝内门体静脉分流术后肝性脑病的治疗

    Clinical efficacy of interventional therapy via TIPS approach for the treatment of acute or subacute portal venous thrombosis

  17. 实验性肝性脑病小鼠脑组织对血中GABA摄取的改变

    Change of brain uptake of blood GABA in experimental hepatic encephalopathy in mice

  18. 目的研究亚临床期肝性脑病(SHE)患者的MRI特征、基底节区的脑血流灌注模式及锥体外系损伤的表现。

    Objective To investigate MRI characteristics , brain perfusion pattern in basal ganglion and extrapyramidal symptoms in patients with subclinical hepatic encephalopathy ( SHE ) .

  19. NA在大鼠CLF所致肝性脑病时明显下降。

    The content of NA decreases remarkably in CLF encephalopathy .

  20. 肝性脑病(hepaticencephalopathy,HE)是肝衰竭的一种严重并发症,其死亡率极高,严重危害人类的健康。

    The hepatic encephalopathy ( HE ) is a serious complication of liver failure with a high mortality and serious harm to human health .

  21. 结论HA中性大孔树脂血浆吸附治疗肝性脑病、脑水肿、全身性炎性反应综合征等方面具有较好的应用价值,且具有安全性高的特点。

    Conclusions : Plasma adsorption technique with HA microporous resin can be applied safely as therapeutic management for HE , brain oedema and SIRS .

  22. 目的探讨脑电图(EEG)及脑地形图(BEAM)对亚临床肝性脑病(SHE)诊断及其临床意义。

    Objective To investigate the diagnostic and clinical values of electroencephalogram ( EEG ) and brain electrical activity mapping ( BEAM ) in sub-clinical hepatic encephalopathy ( SHE ) .

  23. 结论CO作为一种信使分子,不仅参与肝硬化大鼠低血压的发生,还与血脑屏障通透性增加有关,可能是肝硬化诱发肝性脑病的重要介质之一。

    Conclusion Carbon monoxide , involving in the occurrence of hypotension and the increase of blood brain barrier permeability , may play a role in the development of hepatic encephalopathy .

  24. 目的探讨分子吸附再循环系统(MARS)治疗肝性脑病(HE)的疗效和护理。

    Objective To explore the the curative and nursing effect of molecular absorbent recirculating system ( MARS ) on encephalopathy ( HE ) .

  25. 肝性脑病大鼠GABA-A受体亚单位mRNA的表达

    The expression of GABA-A receptor subunit α 1 β 1 γ 2 mRNA in hepatic encephalopathic rats

  26. 对5例慢性肝性脑病病人进行MRI和~1H-MRS复查,其中3例肝移植病人分别于术后1个月、3个月、6个月进行重复性检查。

    Besides 5 patients with HE were underwent repetitive MRI and ~ 1H spectroscopic examinations and 3 of them followed at one months , three months , six months after liver transplantation .

  27. 目的探讨不同类型慢性肝性脑病的临床特征及与脑电图(EEG)、头颅MRI及肝脏功能之间的关系。

    Objective To probe the relationship between clinical features in acquired chronic hepatic encephalopathy ( CHE ) and the EEG , cranial MRI and laboratory findings of the liver funtion .

  28. 3T磁共振波谱分析在轻微型肝性脑病诊断中的应用

    Application of 3T proton magnetic resonance spectroscopy in diagnosis of minimal hepatic encephalopathy

  29. 目的探讨经颈静脉肝内门体分流(TIPS)术前肝血流动力学的不同状态与术后发生肝性脑病的相关性。

    Objective To study the relationship between pre transjugular intrahepatic portosystemic shunt ( TIPS ) liver hemodynamics and the incidence of post TIPS hepatic encephalopathy ( HE ) .

  30. 目的观察HA中性大孔树脂血浆吸附治疗重型肝炎肝性脑病的治疗效果,探讨肝性脑病新的治疗方法。

    Objectives : The aim of this study is to evaluate the therapeutic effectiveness of plasma adsorption with HA microporous resin in patients of severe hepatitis with hepatic encephalopathy .